Last updated on April 16, 2014 at 13:58 EDT

Immunoassays Market Worth $19.1 Billion by 2018

October 29, 2013

DALLAS, October 29, 2013 /PRNewswire/ –

The “Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence,
Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer,
Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global
Forecast to 2018″, provides a detailed overview of the major drivers, restraints,
challenges, opportunities, current market trends, and strategies impacting the global
immunoassays market along with the estimates and forecasts of the revenue and share

Browse 118 market data tables with 86 figures spread through 421 pages and in-depth
TOC on “Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence,
Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer,
Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global
Forecast to 2018″.


Early buyers will receive 10% customization on this report.

The global Immunoassays Market is segmented by technology, application, product
(analyzers and reagents), and end user. The global Immunoassays Market, by technology, is
further segmented into enzyme immunoassays, fluorescent immunoassays, chemiluminescence
immunoassays, radioimmunoassays, and others. Enzyme immunoassays accounted for the largest
share of the global immunoassays market in 2012, owing to their long-term presence and
high sensitivity. However, the chemiluminescence Immunoassays Market will see the highest
growth in the next five years, which is attributed to the high-throughput and automation
offered by CLIAs.

On the basis of application, the Immunoassays Market has segments like oncology,
infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity,
toxicology, hematology (anemia), neonatal screening, and others. The infectious diseases
segment commanded the largest share of 35.2% of the Immunoassays Market in 2012 due to the
high specificity of immunoassays in diagnosing these diseases. Oncology will be the
fastest-growing application owing to the high prevalence of cancer diseases worldwide and
the development of a wide array of cancer biomarkers.

The Americas is the largest revenue generator for immunoassays, followed by Europe.
Both markets have reached their maturity phase of growth and are estimated to register mid
single-digit growth rates for the next five years. Asia-Pacific and LATAM are also
expected to grow at a rapid pace during the analysis period owing to the urbanization,
huge investment opportunities in these Immature Markets, and the growing numbers of
diagnostic laboratories in these regions. The growth of the Immunoassays Market will
mainly be driven by countries like China and India that provide a large population base
for companies. Moreover, increasing healthcare spending and government initiatives will
propel the Immunoassays Market in these countries.

The immunoassays segment contributes about one-fourth to the IVD market and is valued
at $13.0 billion in 2013. Immunoassays are characterized by high specificity, sensitivity,
and low costs. It is estimated to be the second-fastest growing sector of IVD after
molecular diagnostics. The Immunoassays Market will be driven by factors such as growing
incidences of chronic and infectious diseases, increasing aging population, ongoing
technological innovations, increasing demand for non-invasive diagnostic tools and
techniques, and the identification and introduction of novel biomarkers. The availability
of novel tests based on condition-specific markers and increasing adoption of immunoassay
tests in emerging countries are also factors that exhibit growth opportunities for the
Immunoassays Market. There is also an increasing demand for Lateral flow (LF) tests due to
the need for immediate medical information and the demand for rapid test results, easy and
convenient access, accuracy, and sensitivity. Thus LF tests are driving the Immunoassays

On the other hand, factors such as the increasing commoditization of certain
immunoassays, stringent regulatory approvals, increasing pricing pressures on leading
players, and reduction in healthcare budget will restrict the growth of the market.

Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories
(U.S.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), Alere, Inc. (U.S.),
Sysmex Corporation (Japan), and DiaSorin S.P.A. (Italy) are the key industry participants.
The Immunoassays Market is dominated by established players and is consolidated, with the
top 5 players occupying more than 80% of the market. The market offers huge barriers for
new entrants as the industry demands high capital investments for R&D and testing and
manufacturing of products. Moreover, companies have to follow stringent regulations to get
product approvals in various countries.

Browse related reports

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems]
[Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) &
Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] -
Forecast To 2017


Molecular Diagnostics Market – Technologies [PCR, DNA Sequencing, Microarray,
Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious
Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global
Opportunities, Competitor Analysis & Forecasts to 2017


About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotives and transportation, banking and financial services,
biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power,
food and beverages, industrial automation, medical devices, pharmaceuticals, agriculture
industry, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.

        Mr. Rohan
        North - Dominion Plaza
        17304 Preston Road
        Suite 800, Dallas, TX 75252
        Tel: +1-888-600-6441
        Email: sales@marketsandmarkets.com
        Visit MarketsandMarkets Blog @


        Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets

Source: PR Newswire